These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. Dobbs ME, Strasser JE, Chu CF, Chalk C, Milligan GN. J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454 [Abstract] [Full Text] [Related]
3. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. Gill N, Deacon PM, Lichty B, Mossman KL, Ashkar AA. J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672 [Abstract] [Full Text] [Related]
4. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. Gill N, Rosenthal KL, Ashkar AA. J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447 [Abstract] [Full Text] [Related]
5. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Milligan GN, Bernstein DI. Virology; 1995 Oct 01; 212(2):481-9. PubMed ID: 7571418 [Abstract] [Full Text] [Related]
6. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Sobek V, Balkow S, Körner H, Simon MM. Eur J Immunol; 2002 Sep 01; 32(9):2490-9. PubMed ID: 12207333 [Abstract] [Full Text] [Related]
7. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. Milligan GN, Bernstein DI, Bourne N. J Immunol; 1998 Jun 15; 160(12):6093-100. PubMed ID: 9637526 [Abstract] [Full Text] [Related]
8. A protective role of interleukin-15 in a mouse model for systemic infection with herpes simplex virus. Tsunobuchi H, Nishimura H, Goshima F, Daikoku T, Suzuki H, Nakashima I, Nishiyama Y, Yoshikai Y. Virology; 2000 Sep 15; 275(1):57-66. PubMed ID: 11017787 [Abstract] [Full Text] [Related]
9. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. Lab Invest; 1994 Mar 15; 70(3):369-80. PubMed ID: 8145530 [Abstract] [Full Text] [Related]
10. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Maccario R, Comoli P, Percivalle E, Montagna D, Locatelli F, Gerna G. Immunology; 1995 May 15; 85(1):49-56. PubMed ID: 7635521 [Abstract] [Full Text] [Related]
11. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Milligan GN, Bernstein DI. Virology; 1997 Mar 03; 229(1):259-68. PubMed ID: 9123869 [Abstract] [Full Text] [Related]
12. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract. Tang VA, Rosenthal KL. J Reprod Immunol; 2010 Dec 03; 87(1-2):39-44. PubMed ID: 20688399 [Abstract] [Full Text] [Related]
13. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis. Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR. J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624 [Abstract] [Full Text] [Related]
14. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. Nakamoto Y, Guidotti LG, Pasquetto V, Schreiber RD, Chisari FV. J Immunol; 1997 Jun 15; 158(12):5692-7. PubMed ID: 9190918 [Abstract] [Full Text] [Related]
15. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. Kodukula P, Liu T, Rooijen NV, Jager MJ, Hendricks RL. J Immunol; 1999 Mar 01; 162(5):2895-905. PubMed ID: 10072539 [Abstract] [Full Text] [Related]
16. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L. Cancer Gene Ther; 2004 Mar 01; 11(3):237-48. PubMed ID: 14739939 [Abstract] [Full Text] [Related]
17. Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis. Bachmann MF, Ohteki T, Faienza KM, Zakarian A, Kägi D, Speiser DE, Ohashi PS. J Immunol; 1997 Nov 01; 159(9):4165-70. PubMed ID: 9379009 [Abstract] [Full Text] [Related]
18. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. Maccario R, Revello MG, Comoli P, Montagna D, Locatelli F, Gerna G. J Immunol; 1993 Feb 15; 150(4):1437-45. PubMed ID: 8381835 [Abstract] [Full Text] [Related]
19. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Ostler T, Davidson W, Ehl S. Eur J Immunol; 2002 Aug 15; 32(8):2117-23. PubMed ID: 12209623 [Abstract] [Full Text] [Related]
20. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Lowin B, Hahne M, Mattmann C, Tschopp J. Nature; 1994 Aug 25; 370(6491):650-2. PubMed ID: 7520535 [Abstract] [Full Text] [Related] Page: [Next] [New Search]